Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -64,923 | -45,128 | -30,514 | -15,085 | -132,065 |
| Depreciation Amortization | 454 | 352 | 242 | 128 | 807 |
| Accounts receivable | 6,138 | 6,810 | 124 | 68 | -4,875 |
| Accounts payable and accrued liabilities | 8,447 | 4,484 | 4,107 | 1,664 | -4,188 |
| Other Working Capital | 2,672 | -564 | -1,176 | -1,935 | 10,922 |
| Other Operating Activity | 99 | 64 | 4,167 | 2,103 | 109,324 |
| Operating Cash Flow | $-47,113 | $-33,982 | $-23,050 | $-13,057 | $-20,075 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -111 | -87 | -64 | -43 | -121 |
| Purchase Of Investment | -39,732 | -35,124 | -29,926 | -9,996 | -119,982 |
| Sale Of Investment | 89,041 | 74,040 | 54,989 | 29,991 | 86,144 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -35,810 |
| Other Investing Activity | -833 | -833 | -833 | -833 | -35,810 |
| Investing Cash Flow | $48,365 | $37,996 | $24,166 | $19,119 | $-69,769 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 0 | N/A | N/A | 74,945 |
| Other Financing Activity | -5,862 | -3,328 | -284 | -275 | -409 |
| Financing Cash Flow | $-5,862 | $-3,328 | $-284 | $-275 | $74,536 |
| Beginning Cash Position | 24,570 | 24,570 | 24,570 | 24,570 | 39,878 |
| End Cash Position | 19,960 | 25,256 | 25,402 | 30,357 | 24,570 |
| Net Cash Flow | $-4,610 | $686 | $832 | $5,787 | $-15,308 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,113 | -33,982 | -23,050 | -13,057 | -20,075 |
| Capital Expenditure | -111 | -87 | -64 | -43 | -121 |
| Free Cash Flow | -47,224 | -34,069 | -23,114 | -13,100 | -20,196 |